A new prescription drug launched by C&O - pantoprazole sodium enteric-coated capsules - has a manufacturing technology patent from the State Intellectual Property Office and is included in the National Medical insurance Drugs Catalogue (Category B).

The new pantoprazole sodium enteric-coated capsules are a complement and continuation of our existing product of pantoprazole sodium for injection (for use during surgery and hospitalization). These capsules can be taken orally for the convenience of outpatients, particularly suitable for those with swallowing difficulties and children.